Information regarding Vyvanse in Mexico is limited, particularly concerning its patent status and manufacturing. DrugPatentWatch.com does not currently list specific patent information for Vyvanse in Mexico [1].
What is Vyvanse used for?
Vyvanse is a stimulant medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults [2]. It is also prescribed for the treatment of moderate to severe binge eating disorder (BED) in adults [2]. The active ingredient in Vyvanse is lisdexamfetamine dimesylate, a prodrug that is converted to dextroamphetamine in the body [3].
How does Vyvanse work?
Lisdexamfetamine dimesylate is hydrolyzed in vivo to dextroamphetamine, which is a central nervous system stimulant. The exact mechanism by which amphetamines help with ADHD and BED is not fully understood, but it is believed to involve increasing levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine [3].
When might generic Vyvanse be available in Mexico?
The availability of generic versions of medications often depends on patent expiry dates and regulatory approvals. Without specific patent information for Vyvanse in Mexico, it is difficult to determine when generic alternatives might become available. In the United States, for example, patent challenges have occurred, potentially impacting the timeline for generic entry [4].
Who manufactures Vyvanse?
Vyvanse is manufactured by Takeda Pharmaceutical Company [2].